Tailored Dietary Supplements for Consistent Regenerative Therapies
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing autologous regenerative therapies, such as PRP and BMA, suffer from variability in composition and function due to patient-specific factors like age and sex, limiting their effectiveness and introducing both beneficial and detrimental factors.
Innovation Solution
A tailored dietary supplement comprising fatty acids, minerals, vitamins, antioxidants, and botanicals is administered orally to enhance the biological potential of regenerative therapies by optimizing the donor tissue before extraction and the patient's host environment.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Adaptability or versatility
If autologous plasma or bone marrow is used for regenerative therapy, then the treatment can be performed with patient-specific tissues, but the composition and function vary widely between patients due to factors like age and sex
Solution Approach 1:
The patent applies preliminary action by having patients take specific nutritional supplements (omega-3 fatty acids, vitamin D, vitamin K2, magnesium) before undergoing autologous plasma or bone marrow extraction. This pre-treatment approach aims to optimize the composition and biological potential of the extracted tissues in advance, ensuring more consistent and enhanced therapeutic outcomes across different patients regardless of their age or sex
2Reliability
If dietary supplements are administered to enhance regenerative therapy, then the biological potential and consistency of the therapy are improved, but the treatment protocol becomes more complex
Solution Approach 1:
The patent applies parameter changes by modifying the nutritional status of patients through specific supplementations (omega-3 fatty acids, vitamin D, vitamin K2, magnesium) before tissue extraction. This changes the biochemical parameters of the autologous tissues, enhancing their regenerative potential and consistency without requiring complex procedural modifications during the actual therapy
Data Source
AI summary
This invention involves a nutritional or dietary supplement composition that optimizes the beneficial factors and effects of autologous regenerative medicine therapies and non-autologous regenerative medicine therapies. The supplement is comprised of ingredients specific to the clinical application. The ingredients include various types of herbs or other botanicals, spices, amino acids, carbohydrates, dietary sources of fatty acids including various oils, ions, vitamins, antioxidants, enzymes or other dietary substance. An individual or donor is administered a tailored supplement formulation for a specific clinical indication. After the tailored supplemental formulation has been in the donor, the next step is to extract the enhanced tissue or cells or blood components, at, from the individual or donor. The supplement is administered at defined times prior to regenerative medicine therapy. The ingredients of the supplement can be provided in forms including teas, powder, tablet, liquid, or capsule for oral ingestion.